These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
242 related items for PubMed ID: 10511314
1. Regulation of c-Myc and Max in megakaryocytic and monocytic-macrophagic differentiation of K562 cells induced by protein kinase C modifiers: c-Myc is down-regulated but does not inhibit differentiation. Lerga A, Crespo P, Berciano M, Delgado MD, Cañelles M, Calés C, Richard C, Ceballos E, Gutierrez P, Ajenjo N, Gutkind S, León J. Cell Growth Differ; 1999 Sep; 10(9):639-54. PubMed ID: 10511314 [Abstract] [Full Text] [Related]
2. Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells. Delgado MD, Lerga A, Cañelles M, Gómez-Casares MT, León J. Oncogene; 1995 Apr 20; 10(8):1659-65. PubMed ID: 7731722 [Abstract] [Full Text] [Related]
3. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway. Jalava A, Akerman K, Heikkilä J. J Cell Physiol; 1993 May 20; 155(2):301-12. PubMed ID: 8482723 [Abstract] [Full Text] [Related]
4. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh. Naderi S, Blomhoff HK. J Cell Physiol; 1999 Jan 20; 178(1):76-84. PubMed ID: 9886493 [Abstract] [Full Text] [Related]
5. Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells. Larsson LG, Bahram F, Burkhardt H, Lüscher B. Oncogene; 1997 Aug 07; 15(6):737-48. PubMed ID: 9264414 [Abstract] [Full Text] [Related]
6. 12-O-tetradecanoylphorbol-13-acetate and staurosporine induce increased retinoblastoma tumor suppressor gene expression with megakaryocytic differentiation of leukemic cells. Yen A, Varvayanis S, Platko JD. Cancer Res; 1993 Jul 01; 53(13):3085-91. PubMed ID: 8363661 [Abstract] [Full Text] [Related]
7. Analysis of Myc/Max/Mad network members in adipogenesis: inhibition of the proliferative burst and differentiation by ectopically expressed Mad1. Pulverer B, Sommer A, McArthur GA, Eisenman RN, Lüscher B. J Cell Physiol; 2000 Jun 01; 183(3):399-410. PubMed ID: 10797315 [Abstract] [Full Text] [Related]
13. Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells. Wiener Z, Ontsouka EC, Jakob S, Torgler R, Falus A, Mueller C, Brunner T. Exp Cell Res; 2004 Sep 10; 299(1):227-35. PubMed ID: 15302589 [Abstract] [Full Text] [Related]
15. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway. Wang Z, Ge L, Wang M, Carr BI. J Cell Physiol; 2006 Jul 10; 208(1):133-40. PubMed ID: 16596619 [Abstract] [Full Text] [Related]
16. Retinoic acid-induced growth arrest and differentiation of neuroblastoma cells are counteracted by N-myc and enhanced by max overexpressions. Peverali FA, Orioli D, Tonon L, Ciana P, Bunone G, Negri M, Della-Valle G. Oncogene; 1996 Jan 18; 12(2):457-62. PubMed ID: 8570225 [Abstract] [Full Text] [Related]
17. YY1 can inhibit c-Myc function through a mechanism requiring DNA binding of YY1 but neither its transactivation domain nor direct interaction with c-Myc. Austen M, Cerni C, Lüscher-Firzlaff JM, Lüscher B. Oncogene; 1998 Jul 30; 17(4):511-20. PubMed ID: 9696045 [Abstract] [Full Text] [Related]